Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP263444.RAAwffOAN231JjahfrUqTTutuOPpWw4sJ0TkNU9ynUQ_E130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP263444.RAAwffOAN231JjahfrUqTTutuOPpWw4sJ0TkNU9ynUQ_E130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP263444.RAAwffOAN231JjahfrUqTTutuOPpWw4sJ0TkNU9ynUQ_E130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP263444.RAAwffOAN231JjahfrUqTTutuOPpWw4sJ0TkNU9ynUQ_E130_provenance.
- NP263444.RAAwffOAN231JjahfrUqTTutuOPpWw4sJ0TkNU9ynUQ_E130_assertion description "[The authors measured TPMT activity as well as erythrocyte levels of 6TGN (E-6TGN) and methylated 6MP metabolites (E-MeMP) during 6MP therapy in 439 children with acute lymphoblastic leukemia, 5 of whom later developed secondary myelodysplasia or acute myeloid leukemia (sMDS/AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP263444.RAAwffOAN231JjahfrUqTTutuOPpWw4sJ0TkNU9ynUQ_E130_provenance.
- NP263444.RAAwffOAN231JjahfrUqTTutuOPpWw4sJ0TkNU9ynUQ_E130_assertion evidence source_evidence_literature NP263444.RAAwffOAN231JjahfrUqTTutuOPpWw4sJ0TkNU9ynUQ_E130_provenance.
- NP263444.RAAwffOAN231JjahfrUqTTutuOPpWw4sJ0TkNU9ynUQ_E130_assertion SIO_000772 10491537 NP263444.RAAwffOAN231JjahfrUqTTutuOPpWw4sJ0TkNU9ynUQ_E130_provenance.
- NP263444.RAAwffOAN231JjahfrUqTTutuOPpWw4sJ0TkNU9ynUQ_E130_assertion wasDerivedFrom befree-2016 NP263444.RAAwffOAN231JjahfrUqTTutuOPpWw4sJ0TkNU9ynUQ_E130_provenance.
- NP263444.RAAwffOAN231JjahfrUqTTutuOPpWw4sJ0TkNU9ynUQ_E130_assertion wasGeneratedBy ECO_0000203 NP263444.RAAwffOAN231JjahfrUqTTutuOPpWw4sJ0TkNU9ynUQ_E130_provenance.
- befree-2016 importedOn "2016-02-19" NP263444.RAAwffOAN231JjahfrUqTTutuOPpWw4sJ0TkNU9ynUQ_E130_provenance.